Pfizer Inc. (PFE)
NYSE: PFE · Real-Time Price · USD
24.05
+0.15 (0.63%)
At close: Sep 17, 2025, 4:00 PM EDT
24.12
+0.07 (0.29%)
After-hours: Sep 17, 2025, 7:59 PM EDT
Pfizer Revenue
Pfizer had revenue of $14.65B in the quarter ending June 29, 2025, with 10.31% growth. This brings the company's revenue in the last twelve months to $63.83B, up 13.53% year-over-year. In the year 2024, Pfizer had annual revenue of $63.63B with 6.84% growth.
Revenue (ttm)
$63.83B
Revenue Growth
+13.53%
P/S Ratio
2.14
Revenue / Employee
$788,062
Employees
81,000
Market Cap
136.74B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 63.63B | 4.07B | 6.84% |
| Dec 31, 2023 | 59.55B | -41.62B | -41.14% |
| Dec 31, 2022 | 101.18B | 19.89B | 24.46% |
| Dec 31, 2021 | 81.29B | 39.64B | 95.16% |
| Dec 31, 2020 | 41.65B | 746.00M | 1.82% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
PFE News
- 8 hours ago - Arvinas, Pfizer to grant commercial rights of experimental breast cancer drug to third party - Reuters
- 5 days ago - Pfizer, Moderna shares plunge on report that Trump officials plan to link 25 child deaths to COVID vaccine - New York Post
- 5 days ago - Meet 16 Ideal "Safer" September Dividend Dogs Of The S&P500 - Seeking Alpha
- 5 days ago - COVID vaccine makers' shares fall as Trump officials to link shots to child deaths, report says - Market Watch
- 5 days ago - Pfizer, Moderna shares fall on report that Trump officials will link child deaths to Covid shots - CNBC
- 6 days ago - Pfizer's Comeback Accelerates - Seeking Alpha
- 7 days ago - US tariffs, pricing risks to be manageable for Big Pharma, Morningstar says - Reuters
- 7 days ago - Trump's Going After Prescription Drug Ads. What It Means for Pharmaceutical Sales. - Barrons